Wetter Pharma-Fertigung GmbH & Co KG (manufacturing of unpackaged products, primary packaging, in-process control, testing for sterility and bacterial endotoxins; testing for sterility and bacterial endotoxins, visual inspection during manufacturing)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of rheumatoid arthritis (in adults), polyarticular juvenile idiopathic arthritis (in children from 2 years of age), giant cell arteritis (in adults), and systemic juvenile idiopathic arthritis (in children from 1 year of age).
Dosage form: solution for injection
Active substance Dosage tocilizumab 162 mg/0.9 mL ATC: L04AC07